Skip to Content
  • Review
  • Open Access

11 February 2022

11 Pages

A Comprehensive Review of Neuromuscular Manifestations of COVID-19 and Management of Pre-Existing Neuromuscular Disorders in Children

,
,
,
and
1
Penn State College of Medicine Medical Scientist Training Program, Hershey, PA 17033, USA
2
Department of Pediatrics and Neurology, Penn State Health Children’s Hospital, Penn State College of Medicine, Hershey, PA 17033, USA
3
Department of Neurology, University of Texas Rio Grande Valley, Edinburg, TX 78539, USA
*
Author to whom correspondence should be addressed.
This article belongs to the Section Clinical Neurology

Abstract

Since the emergence of SARS-CoV-2, several studies have been published describing neuromuscular manifestations of the disease, as well as management of pre-existing pediatric neuromuscular disorders during the COVID-19 pandemic. These disorders include muscular dystrophies, myasthenic syndromes, peripheral nerve disorders, and spinal muscular atrophy. Such patients are a vulnerable population due to frequent complications such as scoliosis, cardiomyopathy, and restrictive lung disease that put them at risk of severe complications of COVID-19. In this review, neuromuscular manifestations of COVID-19 in children and the management of pre-existing pediatric neuromuscular disorders during the COVID-19 pandemic are discussed. We also review strategies to alleviate pandemic-associated disruptions in clinical care and research, including the emerging role of telemedicine and telerehabilitation to address the continued special needs of these patients.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.